Reveles and Evoy Earn Promotions

A woman and a man smiling.
February 25, 2022
Two of the college's distinguished faculty in the Division of Pharmacotherapy were recommended for promotion by President Hartzell. Dr. Kelly R. Reveles will assume the rank of associate professor and Dr. Kirk Evoy will become a clinical associate professor. Both promotions go into effect September 1, 2022.

Opioid Use Disorder Paper Earns ACCP Award

A box of naloxone vials.
October 8, 2021
A paper from UT College of Pharmacy researchers was awarded the 2021 Outstanding Paper of the Year from the American College of Clinical Pharmacy (ACCP) Ambulatory Care Practice Research Network. The paper investigates the availability of buprenorphine and naloxone in Texas to treat opioid use disorder.

UT Austin Students Earn Diversity Leadership Awards

TADOHE: Texas Association of Diversity Officers in Higher Education
June 14, 2021
The University of Texas at Austin community members won several Emerging Leaders Spotlight Awards during the recent chapter meeting of the Texas Association of Diversity Officers in Higher Education (TADOHE). The inaugural awards seek to highlight and acknowledge individuals in higher education who actively support TADOHE’s mission and diversity, equity, accessibility and inclusion (DEAI) as a whole.

Nixon and Hill Earn Faculty Promotions

A woman smiling and a man wearing glasses.
March 24, 2021
Two of the College of Pharmacy’s distinguished faculty were recently promoted due to their outstanding accomplishments in research, outreach and education. Dr. Kimberly Nixon of the Division of Pharmacology and Toxicology will assume the rank of professor and Dr. Lucas G. Hill of the Division of Pharmacy Practice will become a clinical associate professor.

Live Subject Testing Shows Promising Delivery Method for COVID-19 Antiviral Treatment

A microscopic image.
September 23, 2020
Live subject testing results from the Williams Lab show that dry powder inhalation could be a potent and effective delivery method of the antiviral remdesivir to treat patients affected by COVID-19.

UT Pharmacy Hosts Virtual Discussion on Systemic Racism in the Age of COVID

Assistant Dean of Diversity and Inclusion Skyller Walkes, Ph.D. leads a virtual discussion on June 16, 2020.
July 17, 2020
In addition to numerous statements, resources, and ways to support Black, Indigenous and People of Color, UT College of Pharmacy Assistant Dean of Diversity and Inclusion Skyller Walkes, Ph.D. hosted a long overdue virtual forum discussion on June 16 that synthesized these many feelings and concerns.

Juneteenth

June 19, 2020
A personal letter from Skyller Walkes, Ph.D. to the College of Pharmacy community.

Statement by The Coalition of Diversity and Inclusion Officers, University of Texas at Austin

June 1, 2020
UT diversity officers, including College of Pharmacy Assistant Dean of Diversity and Inclusion Skyller Walkes, Ph.D., offer their support and solidarity to the Black community and everyone at The University of Texas at Austin.

Statement on Gender Equity and Underrepresented Minorities

May 14, 2020
Assistant Dean of Diversity and Inclusion Skyller Walkes, Ph.D. addresses the trend of “othering” during COVID-19, and reaffirms the College of Pharmacy’s commitment to inclusion and equity.

New Delivery Method Could Make Niclosamide an Effective Antiviral to Treat COVID-19

Two men in suits smiling.
April 6, 2020
A team of researchers in the college, led by Robert O. (Bill) Williams III and Hugh D. Smyth, is investigating varying methods of drug delivery to repurpose existing drugs in order to treat and prevent serious COVID-19 virus symptoms in patients.